Global Medtech Manufacturer Accelerates Validation from Months to Days
Navigating the validation mindset shift with CSA
Leading medical device companies operate in a fast-paced sector where regulatory compliance and speed to market must coexist.
When major enterprise upgrades appeared on the horizon, this company’s leadership recognized that continuing with a digitized paper validation process could delay critical go-live dates by several months. Digital validation was no longer a long-term goal; it was an immediate operational necessity.
To prevent validation from becoming a bottleneck, their team searched for a robust, digital solution that would support their business, other major system implementations, and the transition from Computer System Validation (CSV) to Computer Software Assurance (CSA).
“Adopting CSA wasn’t just about software; it was also about shifting our mindset”, said a program manager. “We had to prove to our quality organization that we could maintain rigorous compliance while drastically reducing unnecessary paperwork.”
Limitations of paper-based validation
Before, the company relied on a hybrid, “digital-paper” validation process. While the company used digital templates in Microsoft Word and Excel, the actual execution of those tests remained deeply manual.
“It was a manual, paper-based cycle that forced us to spend countless hours managing documents, routing signatures, and tracking down physical folders than we were actually testing our software,” shared a business administrator.
This hybrid method created severe friction points across the quality lifecycle, including:
- Administrative overhead: Testers had to manually copy and paste requirements, leaving significant room for transcription errors.
- Manual traceability: Traceability matrices were maintained by hand in spreadsheet grids, requiring hundreds of hours of manual verification to ensure every test script matched its corresponding requirement.
- Inflexible approvals: Because reviews were tied to entire document packages, the team was often flooded with large approval backlogs at the end of a project.
Executing 200+ test scripts in nine days
The company sought a partner that aligned with their long-term digital roadmap. The team outlined key requirements, including: native risk-based validation, an intuitive interface, automated traceability, and electronic test execution. After evaluating four validation lifecycle management (VLM) vendors, a cross-functional team selected Veeva.
The platform’s first major test was the validation of a PLM software cloud migration, which challenged 200+ operational qualification (OQ) test scripts and 550+ distinct validation requirements. Under the legacy digital-paper system, executing this volume of testing would have taken several months.
With Veeva Validation Management, they completed the entire execution phase in just nine days. Several key features enabled this rapid turnaround:
- Instant bulk uploading: The team used spreadsheet utilities to import nearly 600 requirements and test scripts in minutes, saving weeks of manual entry.
- Object-based architecture: By managing requirements and scripts as individual, relational database objects rather than flat files, the team routed test packages for electronic signature progressively, avoiding end-of-project bottlenecks.
- Automated traceability: Veeva Validation Management maintained relationships between requirements and scripts in the background, generating an audit-ready traceability matrix with zero manual upkeep.
“To achieve this scale of testing in nine days using our legacy system would have been unthinkable,” the business administrator noted. “Veeva allowed us to achieve that acceleration while remaining fully compliant.”
Achieving real-time visibility and seamless user adoption
Throughout the nine-day execution window, Veeva Validation Management provided leadership with unprecedented, real-time visibility. Using Veeva’s out of the box reports and dashboards functionality, they tracked real-time test script statuses and workload distribution across executors.
This visibility allowed the team to adjust resources in real time. When the data revealed any bottlenecks in the QA approval phase, they were able to immediately scale the approval team, keeping the project on track.
“Within the Veeva Vault platform, I could look at a dashboard in real time and see who was working on what, which let us spot and resolve approval bottlenecks before they delayed our timeline,” said a program manager.
Despite the steep learning curves typically associated with new enterprise quality software, the organization experienced exceptional user adoption.
In a post-implementation survey, one team member shared: “My experience with Veeva was unmatched compared to previous participation in validation efforts. The software and process is a mile ahead of any of my experiences in the past.”
Scaling digital validation across the enterprise
Rather than viewing digital validation as a siloed success, the company structured a multi-year roadmap to scale the Veeva platform across its global business. IT and quality teams are collaborating to integrate automated testing frameworks. By ingesting automated test scripts directly into Veeva, the company plans to accelerate cycle times even further while optimizing its engineering resources.
“The success of this validation project has built massive momentum across the enterprise,” the business administrator concluded. “We are already using Veeva to streamline our upcoming global ERP implementation, and our long-term vision is to connect our entire quality, product, and manufacturing validation processes into a single source of truth.”
By establishing a unified, digital validation framework, this medtech company successfully transitioned validation from an operational hurdle into a strategic business accelerator—safeguarding patient safety, ensuring continuous compliance, and paving the way for rapid enterprise growth.
—Discover how forward-thinking medtech companies leverage CSA principles to streamline testing, maintain real-time audit readiness, and accelerate time-to-market